Get Gtcat

The Morisky Medication Adherence Scale (MMAS) was used as the fifth part of the instrument to evaluate the adherence to the glaucoma medication. The MMAS is composed of four questions that are answered as yes (= 1) or no (= 0). The total score ranges from zero to four.

The Morisky Medication Adherence Scale (MMAS) was used as the fifth part of the instrument to evaluate the adherence to the glaucoma medication. The MMAS is composed of four questions that are answered as yes (= 1) or no (= 0). The total score ranges from zero to four.

HOW COMMON IS NONCOMPLIANCE? Several published studies suggest that medical compliance among glaucoma patients is poor and that between 20% and 66% of them do not use their medication as prescribed.

HOW COMMON IS NONCOMPLIANCE? Several published studies suggest that medical compliance among glaucoma patients is poor and that between 20% and 66% of them do not use their medication as prescribed.

What is The Glaucoma Treatment Compliance Assessment Tool (GTCAT)? We used the framework of the Health Belief Model to create the Glaucoma Treatment Compliance Assessment Tool (GTCAT), a questionnaire designed to evaluate multiple behavioral factors associated with glaucoma medication adherence.

What is The Glaucoma Treatment Compliance Assessment Tool (GTCAT)? We used the framework of the Health Belief Model to create the Glaucoma Treatment Compliance Assessment Tool (GTCAT), a questionnaire designed to evaluate multiple behavioral factors associated with glaucoma medication adherence.

A 2023 study found that ophNdi1 gene therapy enhances mitochondrial function in retinal ganglion cells (RGC). This finding is relevant to glaucoma and other neurodegenerative diseases associated with impaired mitochondrial function.

A 2023 study found that ophNdi1 gene therapy enhances mitochondrial function in retinal ganglion cells (RGC). This finding is relevant to glaucoma and other neurodegenerative diseases associated with impaired mitochondrial function.

Glaucoma treatment often starts with prescription eye drops. Some may decrease eye pressure by improving how fluid drains from your eye. Others decrease the amount of fluid your eye makes. Depending on how low your eye pressure needs to be, you may be prescribed more than one eye drop.

Glaucoma treatment often starts with prescription eye drops. Some may decrease eye pressure by improving how fluid drains from your eye. Others decrease the amount of fluid your eye makes. Depending on how low your eye pressure needs to be, you may be prescribed more than one eye drop.

The Morisky Medication Adherence Scale is a validated assessment tool used to measure non-adherence in a variety of patient populations. It has been verified and substantiated by numerous studies on a global scale with over 110 versions and over 80 translations.

The Morisky Medication Adherence Scale is a validated assessment tool used to measure non-adherence in a variety of patient populations. It has been verified and substantiated by numerous studies on a global scale with over 110 versions and over 80 translations.

The Morisky Medication Adherence Scale (MMAS) was used as the fifth part of the instrument to evaluate the adherence to the glaucoma medication. The MMAS is composed of four questions that are answered as yes (= 1) or no (= 0). The total score ranges from zero to four.

The Morisky Medication Adherence Scale (MMAS) was used as the fifth part of the instrument to evaluate the adherence to the glaucoma medication. The MMAS is composed of four questions that are answered as yes (= 1) or no (= 0). The total score ranges from zero to four.

3.2. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as 24–59% fail to receive the intended or full effect of the treatment [17]. The barriers to adherence in glaucoma are complex, and glaucoma patients vary widely in the way they take their topical glaucoma medications.

This self-report scale consists of 7 items answered with a yes or no and 1 item with a 5-point Likert scale. The scores of the MMAS-8 range from 0 to 8. A score below 6 indicates low adherence, a score between 6 < 8 medium adherence and a score of 8 high adherence.

The Morisky Medication Adherence Scale (MMAS) was used as the fifth part of the instrument to evaluate the adherence to the glaucoma medication. The MMAS is composed of four questions that are answered as yes (= 1) or no (= 0). The total score ranges from zero to four.